SAB Biotherapeutics

Sioux Falls, United States

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

$85.0M raised

Mar 2026

Post Ipo Equity

Biotechnology Clinical Trials Therapeutics

Top Investors

RA Capital Management Vivo Capital Sanofi RTW Investments Commodore Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SAB Biotherapeutics

How much funding has SAB Biotherapeutics raised?

SAB Biotherapeutics has raised $85.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.

Who are SAB Biotherapeutics's investors?

SAB Biotherapeutics's investors include RA Capital Management, Vivo Capital, Sanofi, RTW Investments, Commodore Capital.

Where is SAB Biotherapeutics headquartered?

SAB Biotherapeutics is headquartered in Sioux Falls, United States.

What does SAB Biotherapeutics do?

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

What stage is SAB Biotherapeutics at?

SAB Biotherapeutics is at the Post Ipo Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2026.

MLA

"SAB Biotherapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/sab-biotherapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). SAB Biotherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sab-biotherapeutics

Wikipedia (cite web)

{{cite web |title=SAB Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sab-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K